COMP <GO>
PRFX vs SBFM // PIOTROSKI F-SCORE QUALITY
PRF Technologies Ltd. (NASDAQ) VS. Sunshine Biopharma Inc. (NASDAQ) • 15-METRIC TALLY: PRFX 2
— SBFM 5
▲ PIOTROSKI F-SCORE QUALITY LEADER: SBFM
LAST: $0.75 (-3.86%) • MKT CAP: $2.6M
piotroski-score
3/9
LAST: $3.33 (+7.07%) • MKT CAP: $2.5M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRFX VS. SBFM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRFX | SBFM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 33.80% | -63.80 | SBFM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -21.40% | -13.60 | SBFM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -17.20% | -42.80 | SBFM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -16.50% | -43.50 | SBFM | /net-margins <GO> |
| Revenue Growth (YoY) | — | 4.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 4/9 | -1.00 | SBFM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.6 | 27.3 | +9.27 | PRFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.6M | $2.5M | $91.0K | PRFX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRFX REV | SBFM REV | PRFX GROSS % | SBFM GROSS % | PRFX FCF | SBFM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.0K | $36.3M | -50.0% | 33.8% | -$4.0M | -$5.5M |
| FY 2024 | $0 | $34.9M | — | 30.6% | -$12.6M | -$14.2M |
| FY 2023 | $0 | $24.1M | — | — | -$6.7M | -$8.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRFX // BETA —
SBFM // BETA —